
Malgorzata A. Walicka
Examiner (ID: 315)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 345 |
| Issued Applications | 187 |
| Pending Applications | 28 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15616117
[patent_doc_number] => 20200078463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => COMPOSITION HAVING IMPROVED WATER SOLUBILITY AND BIOAVAILABILITY
[patent_app_type] => utility
[patent_app_number] => 16/610312
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610312
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610312 | COMPOSITION HAVING IMPROVED WATER SOLUBILITY AND BIOAVAILABILITY | Apr 29, 2018 | Pending |
Array
(
[id] => 15616117
[patent_doc_number] => 20200078463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => COMPOSITION HAVING IMPROVED WATER SOLUBILITY AND BIOAVAILABILITY
[patent_app_type] => utility
[patent_app_number] => 16/610312
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610312
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610312 | COMPOSITION HAVING IMPROVED WATER SOLUBILITY AND BIOAVAILABILITY | Apr 29, 2018 | Pending |
Array
(
[id] => 13461525
[patent_doc_number] => 20180282305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => TRIAZOLES AS NR2B RECEPTOR INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/964794
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964794
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/964794 | Triazoles as NR2B receptor inhibitors | Apr 26, 2018 | Issued |
Array
(
[id] => 17822668
[patent_doc_number] => 11427606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Azithromycin derivatives containing a phosphonium ion as anticancer agents
[patent_app_type] => utility
[patent_app_number] => 16/606340
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18723
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 607
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606340 | Azithromycin derivatives containing a phosphonium ion as anticancer agents | Apr 19, 2018 | Issued |
Array
(
[id] => 13364263
[patent_doc_number] => 20180233671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/955799
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15955799
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/955799 | Material for organic electroluminescent device and organic electroluminescent device using the same | Apr 17, 2018 | Issued |
Array
(
[id] => 15493143
[patent_doc_number] => 20200046760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => ANTIMICROBIAL POLY(ALKYLATED IMIDAZOLIUM) SALTS
[patent_app_type] => utility
[patent_app_number] => 16/605856
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605856
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/605856 | Antimicrobial poly(alkylated imidazolium) salts | Apr 17, 2018 | Issued |
Array
(
[id] => 13364261
[patent_doc_number] => 20180233670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/954795
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15954795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/954795 | Material for organic electroluminescent device and organic electroluminescent device using the same | Apr 16, 2018 | Issued |
Array
(
[id] => 15740443
[patent_doc_number] => 20200109109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => STAT3 INHIBITOR FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/603110
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603110
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603110 | STAT3 inhibitor formulation | Apr 4, 2018 | Issued |
Array
(
[id] => 16367750
[patent_doc_number] => 10799483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-13
[patent_title] => Use of isoxazoline compounds for treating demodicosis
[patent_app_type] => utility
[patent_app_number] => 15/944967
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5882
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944967
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/944967 | Use of isoxazoline compounds for treating demodicosis | Apr 3, 2018 | Issued |
Array
(
[id] => 19325954
[patent_doc_number] => 12043619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Near and shortwave infrared polymethine dyes
[patent_app_type] => utility
[patent_app_number] => 16/499700
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 41
[patent_no_of_words] => 8981
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499700
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/499700 | Near and shortwave infrared polymethine dyes | Apr 2, 2018 | Issued |
Array
(
[id] => 17200060
[patent_doc_number] => 20210340155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => Substituted (4-Hydroxyphenyl)Cycloalkane and (4-Hydroxyphenyl)Cycloalkene Compounds and Uses Thereof as Selective Agonists of the Estrogen Receptor Beta Isoform for Enhanced Memory Consolidation
[patent_app_type] => utility
[patent_app_number] => 16/498122
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498122
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498122 | Substituted (4-Hydroxyphenyl)Cycloalkane and (4-Hydroxyphenyl)Cycloalkene Compounds and Uses Thereof as Selective Agonists of the Estrogen Receptor Beta Isoform for Enhanced Memory Consolidation | Mar 29, 2018 | Abandoned |
Array
(
[id] => 16762290
[patent_doc_number] => 20210107871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => BIARYL SULFONAMIDE DERIVATIVE HAVING FILOVIRUS CELL ENTRY INHIBITION ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/497472
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497472
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497472 | BIARYL SULFONAMIDE DERIVATIVE HAVING FILOVIRUS CELL ENTRY INHIBITION ACTIVITY | Mar 29, 2018 | Abandoned |
Array
(
[id] => 15768665
[patent_doc_number] => 20200115350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => Isoxazole Hydroxamic Acids As Histone Deacetylase 6 Inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/498651
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498651
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498651 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | Mar 28, 2018 | Issued |
Array
(
[id] => 15239311
[patent_doc_number] => 20190374441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => PHOSPHORUS-CONTAINING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/485331
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485331
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485331 | PHOSPHORUS-CONTAINING COMPOUNDS | Mar 28, 2018 | Abandoned |
Array
(
[id] => 13521945
[patent_doc_number] => 20180312515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => NEW BICYCLIC COMPOUNDS AS ATX INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/933731
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15933731
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/933731 | NEW BICYCLIC COMPOUNDS AS ATX INHIBITORS | Mar 22, 2018 | Abandoned |
Array
(
[id] => 16297676
[patent_doc_number] => 20200283399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => METHOD OF PRODUCING POLYMERIZABLE COMPOUND, AND SOLUTION OF POLYMERIZABLE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/497944
[patent_app_country] => US
[patent_app_date] => 2018-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 872
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497944 | METHOD OF PRODUCING POLYMERIZABLE COMPOUND, AND SOLUTION OF POLYMERIZABLE COMPOUND | Mar 18, 2018 | Abandoned |
Array
(
[id] => 16009101
[patent_doc_number] => 20200179393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => COMPOSITIONS AND METHODS FOR AMELIORATING PAIN
[patent_app_type] => utility
[patent_app_number] => 16/641401
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641401 | Compositions and methods for ameliorating pain | Mar 11, 2018 | Issued |
Array
(
[id] => 15363545
[patent_doc_number] => 20200017537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => LINCOSAMIDE DERIVATIVES, PREPARATION AND USE THEREOF AS ANTIMICROBIAL AGENT
[patent_app_type] => utility
[patent_app_number] => 16/491133
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491133
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491133 | Lincosamide derivatives, preparation and use thereof as antimicrobial agent | Mar 8, 2018 | Issued |
Array
(
[id] => 12904954
[patent_doc_number] => 20180193493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => RENAL IMAGING AGENT
[patent_app_type] => utility
[patent_app_number] => 15/915774
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15915774
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/915774 | RENAL IMAGING AGENT | Mar 7, 2018 | Abandoned |
Array
(
[id] => 16853430
[patent_doc_number] => 20210154175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => DESMETHYLANETHOLE TRITHIONE DERIVATIVES FOR THE TREATMENT OF DISEASES LINKED TO MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/491617
[patent_app_country] => US
[patent_app_date] => 2018-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491617 | Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production | Mar 6, 2018 | Issued |